Global dialysis market to hit $141.5b by 2031

Asia Pacific is set to register the highest regional CAGR.

The global hemodialysis and peritoneal dialysis market is projected to grow to $141.5b by 2031, expanding at a compound annual growth rate (CAGR) of 6.6%, according to a new report from MarketsandMarkets.

Within the broader market, the hemodialysis access products subsegment is projected to register the highest CAGR of 10.6% from 2026 to 2031 amongst HD consumable types.

Moreover, home hemodialysis services are expected to grow even faster, at 11.4% CAGR over the same period — signalling a shift toward home-based treatment models.

North America remains the dominant market, accounting for 46.2% of the market in 2025, supported by more than 808,000 patients living with end-stage renal disease in the US alone.

Asia Pacific is set to register the highest regional CAGR through 2031. Growth there is being driven by government-funded dialysis access programs, including India's Pradhan Mantri National Dialysis Programme, alongside volume-based procurement policies in China that have expanded patient enrollment in tier-2 and tier-3 cities.

In-centre hemodialysis services held the largest share of the HD services market in 2026, reflecting the dominance of licensed dialysis centres in delivering care to the majority of ESRD patients. 

By disease indication, ESRD is the largest segment and is also projected to register the highest CAGR, as rising diabetes and hypertension prevalence outpaces transplant availability.